The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients

Nephrology Dialysis Transplantation

Volumn 12, Issue 1, 1997, Pages 145-150

  Nevalainen, P ^a   Lahtela, J T ^a,b   Mustonen, J ^a,b   Pasternack, A ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

CAPD; Glucose metabolism; Insulin dependent diabetes mellitus; Intraperitoneal insulin; Lipoproteins; Uraemia

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LIPID;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WELLBEING;

ADULT; ARTERIOSCLEROSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 0031013912     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.1.145     Document Type: Article

References (29)

1. Scarpioni LL, Ballocchi S, Castelli A, Cecchettin M. Poisetti PG. Continuous ambulatory peritoneal dialysis in diabetic patients. Contrib Nephrol 1990; 84: 60-74
2. Khanna R, Oreopoulos DG. Peritoneal dialysis in diabetic end-stage renal disease. J Diabetic Compl 1989; 3: 12-17
3. Schade DS, Eaton RP, Friedman NM, Spencer WJ. Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man. Diahetologia 1980; 19: 35-39
4. Selam J-L, Raccah D, Jean-Didier N et al. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients. Diabetes Care 1992; 15: 53-58
5. Schmitz O. Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects. Diabetes 1985; 34: 1152-1159
6. Taskinen M-R. Hyperlipidemia in diabetes. Clin Endocrinol Metab 1990; 4: 743-775
7. Stout RW. Diabetes and atherosclerosis-the role of insulin. Diabetologia 1979; 16: 141-150
8. Tschöpe W, Koch M, Bernhard T, Ritz E and The German Study Group Diabetes and Uremia. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Nephron 1993; 64: 354-358
9. Ruotolo G, Parlavecchia M, Taskinen M-R et al. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM: role of increased hepatic lipase activity. Diabetes Care 1994; 17: 6-12
10. Selam J-L, Kashyap ML, Gupta AK et al. Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery. Metabolism 1994; 43: 665-669
11. Micossi P, Bosi E, Cristallo M et al. Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII). Acta Diabetol Lat 1986; 23: 155-164
12. Lahtela JT, Mustonen J, Pasternack A. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment. Clin Sci 1995; 88: 427-432
13. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223
14. Yki-Järvinen H, Koivisto V. Insulin sensitivity in newly diagnosed type I diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab 1984; 59: 371-378
15. DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia. J Clin Invest 1978; 62: 425-435
16. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 45-86
17. Rizza RA, Gerich JE, Haymond MW et al. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med 1980; 303: 1313-1318
18. Kolterman OG, Greenfield M, Reaven GM, Saekow M, Olefsky JM. Effect of a high carbohydrate diet on insulin binding to adipocytes and on insulin action in vivo in man. Diabetes 1979; 28: 731-736
19. Beck-Nielsen H, Pedersen O, Lindskov HO. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr 1980; 33: 273-278
20. Robert J-J, Chauvet D, Darmaun D, Leblanc H. Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in type 1 (insulin-dependent) diabetic patients. Diabetologia 1993; 36: 1185-1190
21. Zimmerman SW, Johnson CA, O'Brien M. Survival of diabetic patients on continuous ambulatory peritoneal dialysis for over five years. Perit Dial Bull 1987; 7: 26-29
22. Bergström J. Nutrition and mortality in hemodialysis. J Am Soc Nephrol 1995; 6: 1329-1341
23. Blake PG, Flowerdrew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis-predictors and correlations with outcomes. J Am Soc Nephrol 1993; 3: 1501-1507
24. Kjellstrand CM, Hylander B, Collins A. Mortality on dialysis. On the influence of early start, patient characteristics, and transplantation and acceptance rates. Am J Kidney Dis 1990; 15: 483-490
25. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in the chronic renal failure and hemodialysis population. Am J Kidney Dis 1992; 19: 505-513
26. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 184-191
27. Selam J-L, Kashyap M, Alberti KGMM et al. Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites and hormones in type I diabetes mellitus. Metabolism 1989; 38: 908-912
28. Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M. Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. Kidney Int 1990; 37: 980-990
29. Lindholm B, Norbeck HE. Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 1986; 220: 143-151